Auron Therapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
February 25, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$27,000,000

Company Info
Company Description
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Market
Oncology and Inflammatory Disease
Location
Newton, MA, USA
Coinvestors
Apollo Health Ventures, Arkin Bio Ventures, Brightedge, Casdin Capital, DCVC, Franklin Berger, Mubadala Capital, Polaris Partners, Qiming Venture Partners

Links